TATIANNA MAI: Open Payments
NPI 1972183895 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 55 payments from 14 companies in 2025. Trend: 2023 $24 · 2024 $1,234 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 22 | $666 |
| Gilead Sciences, Inc. | 12 | $384 |
| Merck Sharp & Dohme LLC | 3 | $71 |
| Theratechnologies Inc. | 3 | $59 |
| EMD Serono, Inc. | 2 | $44 |
| Napo Pharmaceuticals Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Antares Pharma, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
Products named: RUKOBIA, CABENUVA, APRETUDE, Biktarvy, DOVATO, PIFELTRO, EGRIFTA, Mytesi.
Industry payments across WA — which companies pay providers there.
